Xellia Pharmaceuticals Usa, Llc

Daptomycin

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Xellia Pharmaceuticals Usa, Llc

Daptomycin HCPCS:

J0872

HCPCS Code Descriptor:

Daptomycin (xellia) unrefrig

Category:

J Code

Daptomycin NDCs:

70594-0060-01, 70594-0066-01

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Daptomycin CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Daptomycin:

Daptomycin is a medication manufactured by Xellia Pharmaceuticals Usa, Llc and aligned to the J Code: J0872. Daptomycin is administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0872 Added Date:

1-Jul-24

J0872 Effective Date:

1-Jul-24

J0872 Termination Date:

HCPCS Active

Our team did not identify patient assistance information for Daptomycin
Our team did not identify patient assistance information for Daptomycin
Our team did not identify a source of prescribing information for this medication.
Information regarding Daptomycin’s side effect information can be found at Medline Plus.